Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature

Autoimmunity Reviews

Volumn 13, Issue 2, 2014, Pages 132-137

  Colaci, Michele ^a   Giuggioli, Dilia ^a   Vacchi, Caterina ^a   Lumetti, Federica ^a   Iachetta, Francesco ^b   Marcheselli, Luigi ^b   Federico, Massimo ^b   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Breast cancer; Scleroderma; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE; CYCLOPHOSPHAMIDE;

BREAST CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CLINICAL FEATURE; COHORT ANALYSIS; CROSS LINKING; DISEASE DURATION; FAMILY HISTORY; FOLLOW UP; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MEDICAL EXAMINATION; MORPHEA; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SKIN ULCER; SMOKING; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

BREAST CANCER; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; TIME FACTORS;

EID: 84888006018     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.09.006     Document Type: Review

References (43)

1. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La Montagna G., et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 2002, 81:139-153.
2. Abu-Shakra M., Guillemin F., Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993, 36:460-464.
3. Szekanecz E., Szamosi S., Horváth A., Németh A., Juhász B., Szántó J., et al. Malignancies associated with systemic sclerosis. Autoimmun Rev 2012, 11:852-855.
4. Roumm A.D., Medsger T.A. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985, 28:1336-1340.
5. Rosenthal A.K., McLaughlin J.K., Linet M.S., Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993, 52:531-533.
6. Rosenthal A.K., McLaughlin J.K., Gridley G., Nyrén O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995, 76:910-914.
7. Higuchi M., Horiuchi T., Ishibashi N., Yoshizawa S., Niho Y., Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000, 19:123-126.
8. Hill C.L., Nguyen A.M., Roder D., Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003, 62:728-731.
9. Derk C.T., Rasheed M., Artlett C.M., Jimenez S.A. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006, 33:1113-1116.
10. Joven B.E., Fare R., Colina F., Ramos B., Carreira P.E. Cancer incidence in systemic sclerosis in Spain: results from a single university hospital. Ann Rheum Dis 2009, 68(Suppl. 3):272.
11. Siau K., Laversuch C.J., Creamer P., O'Rourke K.P. Malignancy in scleroderma patients from south west England: a population-based cohort study. Rheumatol Int 2011, 31:641-645.
12. Kang K.Y., Yim H.W., Kim I.J., Yoon J.U., Ju J.H., Kim H.Y., et al. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre. Scand J Rheumatol 2009, 38:299-303.
13. Olesen A.B., Svaerke C., Farkas D.K., Sørensen H.T. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 2010, 163:800-806.
14. Hashimoto A., Arinuma Y., Nagai T., Tanaka S., Matsui T., Tohma S., et al. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Intern Med 2012, 51:1683-1688.
15. Wooten M. Systemic sclerosis and malignancy: a review of the literature. South Med J 2008, 101:59-62.
16. Marasini B., Conciato L., Belloli L., Massarotti M. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009, 22:573-578.
17. Peters-Golden M., Wise R.A., Hochberg M., Stevens M.B., Wigley F.M. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985 Dec, 12(6):1136-1139.
18. Kuo C.F., Luo S.F., Yu K.H., Chou I.J., Tseng W.Y., Chang H.C., et al. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 2012 Feb, 41(1):44-49.
19. Colaci M., Giuggioli D., Sebastiani M., Manfredi A., Vacchi C., Spagnolo P., et al. Lung cancer in scleroderma: results from an Italian Rheumatologic Centre and review of the literature. Autoimmun Rev 2013, 12:374-379.
20. Scope A., Sadetzki S., Sidi Y., Barzilai A., Trau H., Kaufman B., et al. Breast cancer and scleroderma. Skinmed 2006, 5:18-24.
21. Lu T.Y., Hill C.L., Pontifex E.K., Roberts-Thomson P.J. Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study. Rheumatol Int 2008, 28:895-899.
22. Talbott J.H., Barrocas M. Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 1979, 58:182-207.
23. Forbes A.M., Woodrow J.C., Verbov J.L., Graham R.M. Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 1989, 28:65-69.
24. Lee P., Alderdice C., Wilkinson S., Keystone E.C., Urowitz M.B., Gladman D.D. Malignancy in progressive systemic sclerosis-association with breast carcinoma. J Rheumatol 1983, 10:665-666.
25. Chatterjee S., Dombi G.W., Severson R.K., Mayes M.D. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005, 52:2415-2424.
26. Amis E.S., Butler P.F., Applegate K.E., American College of Radiology American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007, 4:272-284.
27. Agenzia Servizi Sanitari Regionali Giofil. Linea guida ASSR sulla diagnostica per immagini. Italian Health Ministry Imaging Guidelines 2004.
28. Bedetti G., Botto N., Andreassi M.G., Traino C., Vano E., Picano E. Cumulative patient effective dose in cardiology. Br J Radiol 2008, 81:699-705.
29. Launay D., Le Berre R., Hatron P.Y., Peyrat J.P., Hachulla E., Devulder B., et al. Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 2004, 23:516-522.
30. Airo' P., Ceribelli A., Cavazzana I., Taraborelli M., Zingarelli S., Franceschini F. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol 2011, 38:1329-1334.
31. Duncan S.C., Winkelmann R.K. Cancer and scleroderma. Arch Dermatol 1979, 115:950-955.
32. http://www-dep.iarc.fr.
33. Hesselstrand R., Scheja A., Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998, 57:682-686.
34. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, 49:1374-1403.
35. Derk C.T. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 2007, 26:1615-1619.
36. Trojanowska M. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 2010, 6:453-460.
37. Wigley F.M. Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009, 36:150-175.
38. Hebbar M., Peyrat J.P. Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int J Biol Markers 2000, 15:15-21.
39. Ioannou M., Pyrpasopoulou A., Simos G., et al. Upregulation of VEGF expression is associated with accumulation of HIF-1α in the skin of naïve scleroderma patients. Mod Rheumatol 2013, [in press].
40. Liakouli V., Cipriani P., Marrelli A., Alvaro S., Ruscitti P., Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 2011, 10:590-594.
41. Perrot-Applanat M., Di Benedetto M. Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion. Cell Adh Migr 2012, 6:547-553.
42. Bareschino M.A., Schettino C., Colantuoni G., et al. The role of anti-angiogenetic agents in the treatment of breast cancer. Curr Med Chem 2011, 18:5022-5032.
43. Lam W.W., Tang A.P., Tse G., Chu W.C. Radiology-pathology conference: papillary carcinoma of the breast. Clin Imaging 2005, 29:396-400.